{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:06:22Z","timestamp":1795111582295,"version":"4.10.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Acute myocardial infarction (AMI) refers to the acute necrosis of part of the myocardium caused by persistent and severe myocardial ischemia. The aim of the study was to investigate the effect of RNA binding motif protein 15 (RBM15) and acyl-CoA synthetase long chain family member 4 (ACSL4) on ischemia\/reperfusion (I\/R)-induced ferroptosis of cardiomyocytes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and results<\/jats:title>\n            <jats:p>AC16 cells were treated with hypoxia\/reoxygenation (H\/R) to establish an in vitro myocardial infarction cell model. Quantitative real-time polymerase chain reaction (qRT-PCR) and western blot assay were used to determine gene expression. Cell Counting Kit-8 (CCK-8) assay was conducted to investigate cell viability. Ferroptosis level was evaluated by commercial kits. N6-methyladenosine (m6A) level was examined by M6A quantification analysis. RNA immunoprecipitation (RIP) assay, methylated RNA Immunoprecipitation (meRIP) assay and dual-luciferase reporter assay were adopted to verify the combination between RBM15 and ACSL4. ACSL4 mRNA stability was analyzed by Actinomycin D treatment. RBM15 mRNA level was increased in AMI patients\u2019 serums and H\/R-induced AC16 cells. Silencing of RBM15 promoted H\/R-mediated AC16 cell viability and inhibited H\/R-induced AC16 cell oxidative stress and ferroptosis. Moreover, it was demonstrated that RBM15 knockdown inhibited m6A modification of ACSL4 and suppressed the stability of ACSL4 mRNA. Furthermore, ACSL4 overexpression restored the effects of RNM15 silencing on H\/R-induced AC16 cell oxidative injury and ferroptosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>RBM15 silencing repressed H\/R-induced ferroptosis in human cardiomyocytes through regulating m6A modification of ACSL4.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41065-025-00453-0","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T09:20:14Z","timestamp":1752830414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["RBM15 promotes hypoxia\/reoxygenation-induced ferroptosis in human cardiomyocytes by mediating m6A modification of ACSL4"],"prefix":"10.1186","volume":"162","author":[{"given":"Yi","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"453_CR1","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ijcard.2012.12.066","volume":"167","author":"R Teixeira","year":"2013","unstructured":"Teixeira R, Goncalves L, Gersh B. Acute myocardial infarction\u2013historical notes. Int J Cardiol. 2013;167:1825\u201334.","journal-title":"Int J Cardiol"},{"key":"453_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0095-4543(05)70167-6","volume":"27","author":"TJ Pollard","year":"2000","unstructured":"Pollard TJ. The acute myocardial infarction. Prim Care. 2000;27:631\u2013vi649.","journal-title":"Prim Care"},{"key":"453_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.ahj.2015.08.005","volume":"170","author":"KP Rentrop","year":"2015","unstructured":"Rentrop KP, Feit F. Reperfusion therapy for acute myocardial infarction: concepts and controversies from inception to acceptance. Am Heart J. 2015;170:971\u201380.","journal-title":"Am Heart J"},{"key":"453_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.mcna.2007.03.005","volume":"91","author":"AP Burke","year":"2007","unstructured":"Burke AP, Virmani R. Pathophysiology of acute myocardial infarction. Med Clin North Am. 2007;91:553\u201372. ix.","journal-title":"Med Clin North Am"},{"key":"453_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.tcm.2022.02.005","volume":"33","author":"M Algoet","year":"2023","unstructured":"Algoet M, Janssens S, Himmelreich U, Gsell W, Pusovnik M, Van den Eynde J, Oosterlinck W. Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends Cardiovasc Med. 2023;33:357\u201366.","journal-title":"Trends Cardiovasc Med"},{"key":"453_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1172\/JCI62874","volume":"123","author":"DJ Hausenloy","year":"2013","unstructured":"Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123:92\u2013100.","journal-title":"J Clin Invest"},{"key":"453_CR7","doi-asserted-by":"publisher","first-page":"e1005287","DOI":"10.1371\/journal.pcbi.1005287","volume":"12","author":"SY Zhang","year":"2016","unstructured":"Zhang SY, Zhang SW, Liu L, Meng J, Huang Y. m6A-Driver: identifying Context-Specific mRNA m6A Methylation-Driven gene interaction networks. PLoS Comput Biol. 2016;12:e1005287.","journal-title":"PLoS Comput Biol"},{"key":"453_CR8","doi-asserted-by":"publisher","first-page":"108613","DOI":"10.1016\/j.biopha.2019.108613","volume":"112","author":"T Sun","year":"2019","unstructured":"Sun T, Wu R, Ming L. The role of m6A RNA methylation in cancer. Biomed Pharmacother. 2019;112:108613.","journal-title":"Biomed Pharmacother"},{"key":"453_CR9","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3892\/ijmm.2020.4746","volume":"46","author":"Y Qin","year":"2020","unstructured":"Qin Y, Li L, Luo E, Hou J, Yan G, Wang D, Qiao Y, Tang C. Role of m6A RNA methylation in cardiovascular disease (Review). Int J Mol Med. 2020;46:1958\u201372.","journal-title":"Int J Mol Med"},{"key":"453_CR10","doi-asserted-by":"publisher","first-page":"1030728","DOI":"10.3389\/fimmu.2022.1030728","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Xu L, Luo S, Sun X, Li J, Pang H, Zhou J, Zhou Y, Shi X, Li X, Huang G, Xie Z, Zhou Z. The m6A methylation profiles of immune cells in type 1 diabetes mellitus. Front Immunol. 2022;13:1030728.","journal-title":"Front Immunol"},{"key":"453_CR11","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s12276-024-01235-w","volume":"56","author":"SH Park","year":"2024","unstructured":"Park SH, Ju JS, Woo H, Yun HJ, Lee SB, Kim SH, Gyorffy B, Kim EJ, Kim H, Han HD, Eyun SI, Lee JH, Park YY. The m(6)A writer RBM15 drives the growth of triple-negative breast cancer cells through the stimulation of Serine and glycine metabolism. Exp Mol Med. 2024;56:1373\u201387.","journal-title":"Exp Mol Med"},{"key":"453_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s10020-023-00615-8","volume":"29","author":"J Fang","year":"2023","unstructured":"Fang J, Wu X, He J, Zhang H, Chen X, Zhang H, Novakovic B, Qi H, Yu X. RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4. Mol Med. 2023;29:23.","journal-title":"Mol Med"},{"key":"453_CR13","doi-asserted-by":"crossref","unstructured":"Wang X, Wu Y, Guo R, Zhao L, Yan J, Gao C. Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Acute Myocardial Infarction, J Immunol Res, 2022;5173761.","DOI":"10.1155\/2022\/5173761"},{"key":"453_CR14","doi-asserted-by":"crossref","unstructured":"Cheng H, Wu J, Li L, Song X, Xue J, Shi Y, Zou Y, Ma J, Ge J. RBM15 protects from myocardial infarction by stabilizing NAE1, JACC Basic Transl Sci, 2024;9:631\u201348.","DOI":"10.1016\/j.jacbts.2024.01.017"},{"key":"453_CR15","doi-asserted-by":"publisher","first-page":"eadk1200","DOI":"10.1126\/sciadv.adk1200","volume":"10","author":"Q Huang","year":"2024","unstructured":"Huang Q, Ru Y, Luo Y, Luo X, Liu D, Ma Y, Zhou X, Linghu M, Xu W, Gao F, Huang Y. Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases. Sci Adv. 2024;10:eadk1200.","journal-title":"Sci Adv"},{"key":"453_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A, Prokisch H, Trumbach D, Mao G, Qu F, Bayir H, Fullekrug J, Scheel CH, Wurst W, Schick JA, Kagan VE, Angeli JP, Conrad M. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13:91\u20138.","journal-title":"Nat Chem Biol"},{"key":"453_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bbi.2021.01.003","volume":"93","author":"Y Cui","year":"2021","unstructured":"Cui Y, Zhang Y, Zhao X, Shao L, Liu G, Sun C, Xu R, Zhang Z. ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammation. Brain Behav Immun. 2021;93:312\u201321.","journal-title":"Brain Behav Immun"},{"key":"453_CR18","doi-asserted-by":"publisher","first-page":"154999","DOI":"10.1016\/j.phymed.2023.154999","volume":"119","author":"Q Yu","year":"2023","unstructured":"Yu Q, Zhang N, Gan X, Chen L, Wang R, Liang R, Jian J. EGCG attenuated acute myocardial infarction by inhibiting ferroptosis via miR-450b-5p\/ACSL4 axis. Phytomedicine. 2023;119:154999.","journal-title":"Phytomedicine"},{"key":"453_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13019-024-02711-0","volume":"19","author":"C Zhao","year":"2024","unstructured":"Zhao C, Li J. METTL14-mediated N6-methyladenosine modification induces the ferroptosis of hypoxia\/reoxygenation-induced cardiomyocytes. J Cardiothorac Surg. 2024;19:265.","journal-title":"J Cardiothorac Surg"},{"key":"453_CR20","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41374-021-00575-9","volume":"101","author":"XW Lv","year":"2021","unstructured":"Lv XW, Wang MJ, Qin QY, Lu P, Qin GW. 6-Gingerol relieves myocardial ischaemia\/reperfusion injury by regulating LncRNA H19\/miR-143\/ATG7 signaling axis-mediated autophagy. Lab Invest. 2021;101:865\u201377.","journal-title":"Lab Invest"},{"key":"453_CR21","doi-asserted-by":"publisher","first-page":"100979","DOI":"10.1016\/j.xcrm.2023.100979","volume":"4","author":"F Deng","year":"2023","unstructured":"Deng F, Hu JJ, Lin ZB, Sun QS, Min Y, Zhao BC, Huang ZB, Zhang WJ, Huang WK, Liu WF, Li C, Liu KX. Gut microbe-derived Milnacipran enhances tolerance to gut ischemia\/reperfusion injury. Cell Rep Med. 2023;4:100979.","journal-title":"Cell Rep Med"},{"key":"453_CR22","doi-asserted-by":"crossref","unstructured":"Song B, Wei D, Yin G, Song X, Wang S, Jia S, Zhang J, Li L, Wu X. Critical role of SIRT1 upregulation on the protective effect of LncRNA ANRIL against hypoxia\/reoxygenation injury in H9c2 cardiomyocytes. Mol Med Rep. 2021;24.","DOI":"10.3892\/mmr.2021.12186"},{"key":"453_CR23","doi-asserted-by":"crossref","unstructured":"Yao H, Xie Q, He Q, Zeng L, Long J, Gong Y, Li X, Li X, Liu W, Xu Z, Wu H, Zheng C, Gao Y. Pretreatment with panaxatriol saponin attenuates mitochondrial apoptosis and oxidative stress to facilitate treatment of myocardial ischemia-reperfusion injury via the regulation of Keap1\/Nrf2 activity, Oxid Med Cell Longev, (2022) 9626703.","DOI":"10.1155\/2022\/9626703"},{"key":"453_CR24","first-page":"e928205","volume":"27","author":"F Wu","year":"2021","unstructured":"Wu F, Wang W, Duan Y, Guo J, Li G, Ma T. Effect of parecoxib sodium on myocardial Ischemia-Reperfusion injury rats. Med Sci Monit. 2021;27:e928205.","journal-title":"Med Sci Monit"},{"key":"453_CR25","doi-asserted-by":"crossref","unstructured":"Francisco J, Del Re DP. Inflammation in myocardial ischemia\/reperfusion injury: Underlying mechanisms and therapeutic potential, antioxidants (Basel), 2023;12.","DOI":"10.3390\/antiox12111944"},{"key":"453_CR26","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1159\/000518879","volume":"146","author":"M Zhou","year":"2021","unstructured":"Zhou M, Yu Y, Luo X, Wang J, Lan X, Liu P, Feng Y, Jian W. Myocardial Ischemia-Reperfusion injury: therapeutics from a Mitochondria-Centric perspective. Cardiology. 2021;146:781\u201392.","journal-title":"Cardiology"},{"key":"453_CR27","doi-asserted-by":"publisher","first-page":"e14952","DOI":"10.7717\/peerj.14952","volume":"11","author":"C Liu","year":"2023","unstructured":"Liu C, Li Z, Li B, Liu W, Zhang S, Qiu K, Zhu W. Relationship between ferroptosis and mitophagy in cardiac ischemia reperfusion injury: a mini-review. PeerJ. 2023;11:e14952.","journal-title":"PeerJ"},{"key":"453_CR28","doi-asserted-by":"crossref","unstructured":"Pan Y, Wang X, Liu X, Shen L, Chen Q, Shu Q. Targeting ferroptosis as a promising therapeutic strategy for ischemia-reperfusion injury. Antioxid (Basel),2022;11.","DOI":"10.3390\/antiox11112196"},{"key":"453_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12964-024-01479-z","volume":"22","author":"J Guo","year":"2024","unstructured":"Guo J, Wang S, Wan X, Liu X, Wang Z, Liang C, Zhang Z, Wang Y, Yan M, Wu P, Fang S, Yu B. Mitochondria-derived methylmalonic acid aggravates ischemia-reperfusion injury by activating reactive oxygen species-dependent ferroptosis. Cell Commun Signal. 2024;22:53.","journal-title":"Cell Commun Signal"},{"key":"453_CR30","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s13577-022-00682-9","volume":"35","author":"P Yu","year":"2022","unstructured":"Yu P, Zhang J, Ding Y, Chen D, Sun H, Yuan F, Li S, Li X, Yang P, Fu L, Yu S, Zhang J. Dexmedetomidine post-conditioning alleviates myocardial ischemia-reperfusion injury in rats by ferroptosis Inhibition via SLC7A11\/GPX4 axis activation. Hum Cell. 2022;35:836\u201348.","journal-title":"Hum Cell"},{"key":"453_CR31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, Yang C, Chen Y. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.","journal-title":"Signal Transduct Target Ther"},{"key":"453_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13578-021-00661-x","volume":"11","author":"X Chen","year":"2021","unstructured":"Chen X, Wang J, Tahir M, Zhang F, Ran Y, Liu Z, Wang J. Current insights into the implications of m6A RNA methylation and autophagy interaction in human diseases. Cell Biosci. 2021;11:147.","journal-title":"Cell Biosci"},{"key":"453_CR33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.7754\/Clin.Lab.2016.160533","volume":"63","author":"J Fan","year":"2017","unstructured":"Fan J, Ma J, Xia N, Sun L, Li B, Liu H. Clinical value of combined detection of CK-MB, MYO, cTnI and plasma NT-proBNP in diagnosis of acute myocardial infarction. Clin Lab. 2017;63:427\u201333.","journal-title":"Clin Lab"},{"key":"453_CR34","doi-asserted-by":"publisher","first-page":"9929687","DOI":"10.1155\/2021\/9929687","volume":"2021","author":"WK Zhao","year":"2021","unstructured":"Zhao WK, Zhou Y, Xu TT, Wu Q. Ferroptosis: opportunities and challenges in myocardial Ischemia-Reperfusion injury. Oxid Med Cell Longev. 2021;2021:9929687.","journal-title":"Oxid Med Cell Longev"},{"key":"453_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, Sun B, Wang G. Ferroptosis: past, present and future. Cell Death Dis. 2020;11:88.","journal-title":"Cell Death Dis"},{"key":"453_CR36","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/tox.23741","volume":"38","author":"J Feng","year":"2023","unstructured":"Feng J, Li Y, He F, Zhang F. RBM15 Silencing promotes ferroptosis by regulating the TGF-beta\/Smad2 pathway in lung cancer. Environ Toxicol. 2023;38:950\u201361.","journal-title":"Environ Toxicol"},{"key":"453_CR37","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1007\/s11010-024-05149-z","volume":"480","author":"Z Huang","year":"2025","unstructured":"Huang Z, Chen P, Liu Y. RBM15-mediated the m6A modification of MAT2A promotes osteosarcoma cell proliferation, metastasis and suppresses ferroptosis. Mol Cell Biochem. 2025;480:2923\u201333.","journal-title":"Mol Cell Biochem"},{"key":"453_CR38","doi-asserted-by":"crossref","unstructured":"Sun C, Guan H, Li J, Gu Y. RBM15-mediated m6A modification of XPR1 promotes the malignant progression of lung adenocarcinoma. Naunyn Schmiedebergs Arch Pharmacol; 2025.","DOI":"10.1007\/s00210-025-03849-x"},{"key":"453_CR39","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1097\/CM9.0000000000002533","volume":"136","author":"K Ding","year":"2023","unstructured":"Ding K, Liu C, Li L, Yang M, Jiang N, Luo S, Sun L. Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism. Chin Med J (Engl). 2023;136:2521\u201337.","journal-title":"Chin Med J (Engl)"},{"key":"453_CR40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-022-01004-z","volume":"7","author":"B Gan","year":"2022","unstructured":"Gan B. ACSL4, PUFA, and ferroptosis: new arsenal in anti-tumor immunity. Signal Transduct Target Ther. 2022;7:128.","journal-title":"Signal Transduct Target Ther"},{"key":"453_CR41","doi-asserted-by":"publisher","first-page":"110629","DOI":"10.1016\/j.intimp.2023.110629","volume":"122","author":"P Chen","year":"2023","unstructured":"Chen P, Wang D, Xiao T, Gu W, Yang H, Yang M, Wang H. ACSL4 promotes ferroptosis and M1 macrophage polarization to regulate the tumorigenesis of nasopharyngeal carcinoma. Int Immunopharmacol. 2023;122:110629.","journal-title":"Int Immunopharmacol"},{"key":"453_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.freeradbiomed.2024.05.014","volume":"220","author":"J Zhou","year":"2024","unstructured":"Zhou J, Tang J, Zhang C, Li G, Lin X, Liao S, Luo J, Yu G, Zheng F, Guo Z, Shao W, Hu H, Xu L, Wu S, Li H. ALKBH5 targets ACSL4 mRNA stability to modulate ferroptosis in hyperbilirubinemia-induced brain damage. Free Radic Biol Med. 2024;220:271\u201387.","journal-title":"Free Radic Biol Med"},{"key":"453_CR43","doi-asserted-by":"publisher","first-page":"628988","DOI":"10.3389\/fphar.2021.628988","volume":"12","author":"Z Fan","year":"2021","unstructured":"Fan Z, Cai L, Wang S, Wang J, Chen B. Baicalin prevents myocardial ischemia\/reperfusion injury through inhibiting ACSL4 mediated ferroptosis. Front Pharmacol. 2021;12:628988.","journal-title":"Front Pharmacol"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00453-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00453-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00453-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T14:07:24Z","timestamp":1757254044000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00453-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["453"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00453-0","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consents were obtained from all participants and this study was permitted by the Ethics Committee of Bishan Hospital of Chongqing, Bishan Hospital of Chongqing Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}